ETF overview
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.
Fund facts
- Expense ratio
- 0.35%
- Fund assets
- 438.63M USD (all share classes)
- Issuer
- SPDR
- Inception date
- Jun 19, 2006
- Number of holdings
- 63
Breakdown
Holdings (63)
| Name | Ticker | Weight |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS INC | XERS | 2.68% |
| PACIRA BIOSCIENCES INC | PCRX | 2.60% |
| VERADERMICS INC | MANE | 2.37% |
| PERRIGO CO PLC | PRGO | 2.36% |
| AMNEAL PHARMACEUTICALS INC | AMRX | 2.29% |
| ELI LILLY + CO | LLY | 2.28% |
| VIATRIS INC | VTRS | 2.26% |
| ZOETIS INC | ZTS | 2.19% |
| PFIZER INC | PFE | 2.17% |
| LIGAND PHARMACEUTICALS | LGND | 2.12% |
| and 50 more | ||
Similar ETFs
- iShares U.S. Pharmaceuticals ETFIHE · Overlap 40% · Expense ratio 0.37%
- Invesco Pharmaceuticals ETFPJP · Overlap 37% · Expense ratio 0.58%
Overlap is the share of assets the two funds hold in common.
Historical returns do not guarantee future returns. This is not investment advice.
- Expense ratio
- 0.35%
- Fund assets
- 438.63M USD (all share classes)
- Issuer
- SPDR
- Inception date
- Jun 19, 2006
- Number of holdings
- 63
| Name | Ticker | Weight |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS INC | XERS | 2.68% |
| PACIRA BIOSCIENCES INC | PCRX | 2.60% |
| VERADERMICS INC | MANE | 2.37% |
| PERRIGO CO PLC | PRGO | 2.36% |
| AMNEAL PHARMACEUTICALS INC | AMRX | 2.29% |
| ELI LILLY + CO | LLY | 2.28% |
| VIATRIS INC | VTRS | 2.26% |
| ZOETIS INC | ZTS | 2.19% |
| PFIZER INC | PFE | 2.17% |
| LIGAND PHARMACEUTICALS | LGND | 2.12% |
| and 50 more | ||
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.
- iShares U.S. Pharmaceuticals ETFIHE · Overlap 40% · Expense ratio 0.37%
- Invesco Pharmaceuticals ETFPJP · Overlap 37% · Expense ratio 0.58%
Overlap is the share of assets the two funds hold in common.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free